目的: 观察微量白蛋白尿及脉压差与冠心病的相关性,探讨上述指标在冠心病的早期诊断、预防以及治疗中的价值。方法: 选取接受冠状动脉造影术检查的患者180例为研究对象,根据冠状动脉造影结果分为非冠心病组(60例)和冠心病组(120例),冠心病组中冠状动脉单支血管病变组35例、双支血管病变组39例、三支血管病变组46例,比较各组患者微量白蛋白尿以及脉压差水平。结果: 冠心病组患者尿微量白蛋白水平高于非冠心病组(t=937.660,P=0.000);此外,冠心病组脉压差高于非冠心病组(t=2.060,P=0.042);各冠状动脉病变支数组间尿微量白蛋白比较,差异有统计学意义(F>999.990,P=0.000),同时,各组间脉压差比较,差异有统计学意义(F=3.822,P=0.023);Logistic回归分析结果显示,脉压差及微量白蛋白尿与冠心病的发生均有相关性(P<0.05)。结论: 微量白蛋白尿以及脉压差与冠心病具有一定的相关性,微量白蛋白尿、脉压差是冠心病的独立危险因素。
Objective: To study the correlation between microalbuminuria and pulse pressure and coronary heart disease and to explore the value of early diagnosis, prevention and treatment of coronary heart disease.Methods: 180 cases of patients examined by coronary angiography were divided non-coronary heart disease group(60 cases)and coronary heart disease group(120 cases)by the results. In the coronary heart disease group, there were 35 cases in single vessel disease grade, 39 cases in double vessel disease grade and 46 cases in three vessel disease grade. The levels of microalbuminuria and pulse pressure in each group were compared.Results: The level of microalbuminuria in coronary heart disease group was significantly higher than that in non-coronary heart disease group (t=937.660,P=0.000). The pulse pressure in coronary heart disease group was significantly higher than that in non-coronary heart disease group (t=2.060, P=0.042). There was statistically significant difference of microalbuminuria in the three coronary heart disease groups (F>999.990, P=0.000) and there was significant difference of pulse pressure in the three groups (F=3.822,P=0.023). Logistic regression analysis showed that pulse pressure and microalbuminuria were correlated with the occurrence of coronary heart disease (P<0.05).Conclusion: Pulse pressure and microalbuminuria are correlated with coronary heart disease. Pulse pressure and microalbuminuria are independent risk factors for coronary heart disease.
[1] Dong HJ,Huang C,Luo DM,et al.Concomitant coronary and renal revascularization improves left ventricular hypertrophy more than coronary stenting alone in patients with ischemic heart and renal disease[J].Zhejiang Univ Sci B,2016,17(1):67-75.
[2] Sharma S, Ghalaut VS, Dixit R,et al. Microalbuminuria and C-reactive proteinas a predictor of coronary artery disease in patients of acute chest pain [J].Cardiovasc Dis Res,2013,4(1):37-39.
[3] 贾永平,姬富才,吕吉元,等.微量白蛋白尿和动态脉压与冠状动脉病变严重程度[J].中华高血压杂志,2009,17(2):149-152.
[4] Kim JJ,Hwang BH,Choi IJ,et al.A prospective two-center study on the associations between microalbuminuria,coronary atherosclerosis and long-term clinical outcome in asymptomatic patients with type 2 diabetes mellitus: evaluation by coronary CT angiography[J].Cardiovasc Imaging,2015,31(1):193-203.
[5] 王议.云南农村自然人群冠状动脉钙化与脉压差及危险因素聚集性的关系的调查研究[D].云南:大理学院,2014.
[6] 张晓锋,邵玉玲,张晓波,等.有创中心动脉压与外周动脉压差及其与冠状动脉病变程度的关系[J].中国介入心脏病学杂志,2013,21(5):301-304.
[7] 赵瑞平,郝志茹.大螺距双源CT冠脉成像和冠状动脉造影的对比研究[J].中国介入心脏病学会杂志,2012,20(3):153-155.
[8] Nageh T,Sherwood RA,Harris BM,et al.Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease[J].Heart,2005,91(9):1181-1185.
[9] 张小梅,纪立农.微量白蛋白尿不同测定方法的比较[J].中国医药导刊,2007,9(3):186-188.
[10] 单海燕,李效娟,李婉,等.老年非杓型高血压患者血压昼夜节律变化与尿微量白蛋白、同型半胱氨酸的相关性[J].山东医药,2013,53(11):22-24.
[11] 刘冬青,赵莲英,樊瑞芬,等.原发性高血压患者尿液足细胞标志蛋白PCX水平测定及分析[J].山东医药,2012,52(43):48-49.
[12] Garg JP,BakrisGL.Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease[J].Vasc Med,2002,7(1):35-43.
[13] Mulvey CK,McNeill AM,Girman CJ,et al.Differential associations of oral glucose tolerance test-derived measures of insulin sensitivity and pancreatic β-cell function with coronary artery calcification and microalbuminuria in type 2 diabetes[J].Diabetes Care,2014,37(1):124-133.
[14] Gerstein HC,Mann JF,Yi Q,et al.Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic andnondiabetic individuals[J].JAMA,2001,286(4):421-426.
[15] Xia F,Liu G,Shi Y,et al.Impact of microalbuminuria on incident coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis of prospective studies[J].Int J Clin Exp Med,2015,8(1):1-9.
[16] 卜四江.冠心病患者尿微量白蛋白水平及动脉硬化指数与冠脉狭窄程度的关系分析[J].临床和实验医学杂志,2015,14(17):1443-1445.
[17] O'Rourke M,Frohlich ED.Pulse pressure: Is this a clinically useful risk factor?[J].Hypertension,1999,34(3):372-374.
[18] 任军梅,王瑞英,刘毅坚,等.老年高血压患者脉压与动脉硬化及动脉内皮功能关系的研究[J].中国心血管病研究杂志,2007,5(1):4-7.
[19] 王宏宇,张维忠,龚兰生,等.高血压合并动脉粥样硬化和大动脉缓冲功能关系的研究[J].中华心血管病杂志,2001,29(4)17-20.
[20] 刘振兵,杨文霞.脉压与颈动脉硬化关系及对患者预后的影响[J].内蒙古医学杂志,2011,43(7):812-814.